| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5431900 | LANTHEUS MEDCL | Ester-substituted diaminedithiols and radiolabeled complexes thereof |
Jul, 2012
(11 years ago) | |
Neurolite is owned by Lantheus Medcl.
Neurolite contains Technetium Tc-99M Bicisate Kit.
Neurolite has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Neurolite are:
- US5431900
Neurolite was authorised for market use on 23 November, 1994.
Neurolite is available in injectable;injection dosage forms.
Neurolite can be used as diagnostic radioimaging.
The generics of Neurolite are possible to be released after 11 July, 2012.
Drugs and Companies using TECHNETIUM TC-99M BICISATE KIT ingredient
Market Authorisation Date: 23 November, 1994
Treatment: Diagnostic radioimaging
Dosage: INJECTABLE;INJECTION
More Information on Dosage
NEUROLITE family patents
